Europe's top court on Thursday rejected French drugmaker Servier's appeal against a finding by EU antitrust regulators a decade ago that its pay-for-delay deals with generic rivals were anti-competitive. The court upheld a fine imposed on Servier for deals with rivals to delay sales of generic copies of its top-selling blood pressure medicine, perindopril. The EU fine amounts to ₹125.62 crore.
French drugmaker Servier on Thursday lost its court battle against a European Union fine for deals with rivals to delay sales of generic copies of its top-selling blood pressure medicine perindopril. https://t.co/DTFKMXiCDJ https://t.co/DTFKMXiCDJ
EU court upholds ₹125.62 crore fine on Unichem for patent dispute settlement https://t.co/b0DiBGbCVo
French drugmaker Servier on Thursday lost its court battle against a European Union fine for deals with rivals to delay sales of generic copies of its top-selling blood pressure medicine perindopril. https://t.co/MHFVTEHU3y https://t.co/MHFVTEHU3y
Europe's top court on Thursday rejected French drugmaker Servier's appeal against a finding by EU antitrust regulators a decade ago that its pay-for-delay deals with generic rivals were anti-competitive. https://t.co/sq4MU2z0Gh https://t.co/sq4MU2z0Gh
EU top court rejects Servier appeal against EU antitrust fine https://t.co/UNGvwtzxXg https://t.co/6fBwYKcAA6
EU TOP COURT REJECTS SERVIER FIGHT AGAINST EU ANTITRUST FINE FOR PAY-FOR-DELAY DEALS